Generic Name and Formulations:
Hydrogen peroxide 40% w/w; topical soln.
Indications for ESKATA:
Raised seborrheic keratoses.
For topical application by healthcare provider. Apply 4 times to targeted lesion(s) approx. 1min apart during a single session. May administer another treatment if lesions have not cleared after 3 weeks.
Not for oral, ophthalmic, or intravaginal use. Avoid open or infected seborrheic keratoses, lesions within orbital rim, eyes and mucous membranes.
Erythema, stinging, edema, scaling, crusting, pruritus, vesiculation, erosion, ulceration, hyper/hypopigmentation.
Pen applicator (1.5mL, 2.2mL)—1, 3, 12
Neurology Advisor Articles
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Serious Adverse Events Profile for Cladribine Confirmed With Extended Data
- Patients With Multiple Sclerosis Face Greater Infection Risk
- Ozanimod Reduces Severe Relapses in Multiple Sclerosis More Than Interferon Beta-1a